Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor.

Lorenzo-Betancor O, García-Martín E, Cervantes S, Agúndez JA, Jiménez-Jiménez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P.

Eur J Neurol. 2011 Aug;18(8):1085-9. doi: 10.1111/j.1468-1331.2010.03251.x.

Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ.

PLoS One. 2011;6(7):e22133. doi: 10.1371/journal.pone.0022133.

Functional electrical stimulation of dorsiflexor muscle: effects on dorsiflexor strength, plantarflexor spasticity, and motor recovery in stroke patients.

Sabut SK, Sikdar C, Kumar R, Mahadevappa M.

NeuroRehabilitation. 2011;29(4):393-400. doi: 10.3233/NRE-2011-0717.

Head tremor related to CACNA1A mutations.

Geerlings RP, Koehler PJ, Haane DY, Stam AH, de Vries B, Boon EM, Haan J.

Cephalalgia. 2011 Sep;31(12):1315-9. doi: 10.1177/0333102411414442.

Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

Lee J, Hwang YJ, Boo JH, Han D, Kwon OK, Todorova K, Kowall NW, Kim Y, Ryu H.

Cell Death Differ. 2011 Nov;18(11):1726-35. doi: 10.1038/cdd.2011.38.

New non-oral drug delivery systems for Parkinson's disease treatment.

Md S, Haque S, Sahni JK, Baboota S, Ali J.

Expert Opin Drug Deliv. 2011 Mar;8(3):359-74. doi: 10.1517/17425247.2011.556616. Review.

Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.

Nandhu MS, Paul J, Kuruvila KP, Abraham PM, Antony S, Paulose CS.

Mol Cell Biochem. 2011 Jul;353(1-2):47-57. doi: 10.1007/s11010-011-0773-x.

Strength and activation of the knee musculature in Parkinson's disease: effect of medication.

Folland JP, Haas B, Castle PC.

NeuroRehabilitation. 2011;29(4):405-11. doi: 10.3233/NRE-2011-0719.

[The pathomechanisms of young-onset Parkinson's disease (PD), approach to the causes of PD form the mechanisms of insulin secretion system].

Hattori N, Eguchi H, Imaizumi M, Saiki S, Sato S, Nagamatsu S.

Rinsho Shinkeigaku. 2011 Nov;51(11):986-7. Japanese. No abstract available.

Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease.

Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, Arai H, Hattori N.

Parkinsonism Relat Disord. 2011 Mar;17(3):189-93. doi: 10.1016/j.parkreldis.2010.12.004.

[Nonsteroidal analgesics have a protective effect against Parkinson disease].

Steurer J.

Praxis (Bern 1994). 2011 May 11;100(10):617-8. doi: 10.1024/1661-8157/a000535. German. No abstract available.

Meclizine is neuroprotective in models of Huntington's disease.

Gohil VM, Offner N, Walker JA, Sheth SA, Fossale E, Gusella JF, MacDonald ME, Neri C, Mootha VK.

Hum Mol Genet. 2011 Jan 15;20(2):294-300. doi: 10.1093/hmg/ddq464.

Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Goodman AO, Barker RA.

Version 2. PLoS Curr. 2011 Feb 28 [revised 2011 Jan 1];3:RRN1214.

Morvan chorea and agrypnia excitata: when video-polysomnographic recording guides the diagnosis.

Provini F, Marconi S, Amadori M, Guaraldi P, Pierangeli G, Cortelli P, Lugaresi E, Montagna P, Tinuper P.

Sleep Med. 2011 Dec;12(10):1041-3. doi: 10.1016/j.sleep.2011.05.005.

Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.

Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE.

Mitochondrion. 2011 Mar;11(2):342-50. doi: 10.1016/j.mito.2010.12.003.